Patents by Inventor Lars Endahl

Lars Endahl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SEMAGLUTIDE IN MEDICAL THERAPY
    Publication number: 20240415935
    Abstract: The present invention relates to semaglutide for use in weight management.
    Type: Application
    Filed: August 30, 2024
    Publication date: December 19, 2024
    Inventors: Marianne Oelholm Larsen Groenning, Lars Endahl, Charlotte Giwercman Carson, Anders Bjerring Strathe, Maria Kabisch, Thomas Hansen
  • SEMAGLUTIDE IN MEDICAL THERAPY
    Publication number: 20240316159
    Abstract: The present invention relates to semaglutide for use in weight management.
    Type: Application
    Filed: June 7, 2024
    Publication date: September 26, 2024
    Inventors: Marianne Oelholm Larsen Groenning, Lars Endahl, Charlotte Giwercman Carson, Anders Bjerring Strathe, Maria Kabisch, Thomas Hansen
  • Semaglutide in medical therapy
    Patent number: 12029779
    Abstract: The present invention relates to semaglutide for use in weight management.
    Type: Grant
    Filed: April 9, 2020
    Date of Patent: July 9, 2024
    Assignee: Novo Nordisk A/S
    Inventors: Marianne Oelholm Larsen Groenning, Lars Endahl, Charlotte Giwercman Carson, Anders Bjerring Strathe, Maria Kabisch, Thomas Hansen